Nymox Pharmaceutical Corporation (NYMX) Has More Upside Potential, Even After Gains

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) just put out data from its long term investigation into the safety and efficacy of its lead prostate candidate...

Keep Reading →